Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas

Stopped early · Phase 3

Conditions studied: Pneumonia

In brief

This is a phase 3, multicenter, open-label, sponsor blinded, randomized active-controlled, parallel group to investigate the efficacy, safety and tolerability of intravenous murepavadin given with ertapenem versus an anti-pseudomonal β-lactam based antibiotic in the treatment of nosocomial pneumonia in adult subjects

Key facts

Study ID

NCT03582007

Run by

Polyphor Ltd.

People needed

2

Starts

2018-10-22

Expected to finish

2019-07-17

Last updated by the study team

2019-08-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Research site — Iowa City, Iowa, United States
• Research Site — Pittsburgh, Pennsylvania, United States
• Research site — Břeclav, Czechia
• Research site — Kolín, Czechia
• Research site — Argenteuil, France
• Research site — Hadera, Israel
• Research site — Tel Aviv, Israel

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.